Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-04-04
2006-04-04
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S380000, C548S240000, C548S243000
Reexamination Certificate
active
07022725
ABSTRACT:
A compound represented by the formula (I)wherein one of R1and R2is a hydrogen atom or a substituent and the other is an optionally substituted cyclic group; W is a bond or a divalent aliphatic hydrocarbon group; Y is a group of the formula: —OR3(wherein R3is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group or an optionally substituted acyl group) or an optionally esterified or amidated carboxyl group, or a salt thereof or a prodrug thereof has a superior insulin secretion promoting action and a hypoglycemic action and shows low toxicity. Therefore, the compound is useful as a pharmaceutical agent, particularly as an agent for the prophylaxis or treatment of diabetes and diabetic complications, and the like.
REFERENCES:
patent: 3752818 (1973-08-01), Plumpe et al.
patent: 5814627 (1998-09-01), Schwab et al.
patent: 6060494 (2000-05-01), Faasch et al.
patent: 0208040 (1987-01-01), None
patent: 0903345 (1999-03-01), None
patent: 69029656 (1969-02-01), None
patent: 54044665 (1979-04-01), None
patent: WP 98/28282 (1998-07-01), None
patent: WO 00/08001 (2000-02-01), None
patent: WO 00/38666 (2000-07-01), None
Fossa. et al. “5-Substituted 4-Isoxazoleacetic Acids with Analgesic Activity” IL FARMACO 49(1):41-44 (1994).
Asakawa Tomoko
Maekawa Tsuyoshi
Momose Yu
Sakai Nozomu
Chao Mark
Ramesh Elaine M.
Shiao Robert
Solola Taofiq
Takeda Pharmaceutical Company Limited
LandOfFree
Isoxazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoxazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoxazole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3606701